Refractory, advanced Mycosis fungoides

Also known as: Refractory advanced Mycosis fungoides / Mycosis fungoides refractory / Refractory Mycosis Fungoides

DrugDrug NameDrug Description
DB00853TemozolomideTemozolomide (Temodar and Temodal) is an oral alkylating agent used for the treatment of refractory anaplastic astrocytoma -- a type of cancerous brain tumor. Temozolomide is not active until it is converted at physiologic pH to the active form, 5-(3-methyltriazen-1-yl)imidazole-4-carboxamide (MTIC).
DrugDrug NamePhaseStatusCount
DB05015Belinostat1Not Yet Recruiting1
DB08870Brentuximab vedotin1Not Yet Recruiting1
DB08889Carfilzomib1Not Yet Recruiting1
DB09331Daratumumab1Not Yet Recruiting1
DB09502Fludeoxyglucose F-181Not Yet Recruiting1
DB00441Gemcitabine1Not Yet Recruiting1
DB00480Lenalidomide1Not Yet Recruiting1
DB09035Nivolumab1Not Yet Recruiting1
DB08935Obinutuzumab1Not Yet Recruiting1
DB09037Pembrolizumab1Not Yet Recruiting1
DB00073Rituximab1Not Yet Recruiting1
DB06176Romidepsin1Not Yet Recruiting1
DB00072Trastuzumab1Not Yet Recruiting1
DB11714Durvalumab1 / 2Recruiting1
DB00480Lenalidomide1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Not Yet Recruiting1
DB06813Pralatrexate1 / 2Not Yet Recruiting1
DB00855Aminolevulinic acid2Recruiting1
DB00033Interferon gamma-1b2Recruiting1
DB06132Nivolumab2Recruiting2
DB09035Nivolumab2Recruiting2
DB09037Pembrolizumab2Recruiting1
DB13896Talimogene laherparepvec2Recruiting1